ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025
Bridging the knowledge gap in rare bone disorders: insights from the APCO Asia-Pacific Rare Bone Disorders Engagement (ASPIRE) survey.
Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Natural history of hypophosphatasia in Chinese patients younger than 18 years: a single-center retrospective observational study.Frontiers in endocrinology · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This first-of-its-kind survey reveals deep gaps in awareness, diagnostic confidence, and access to resources for rare bone disorders across the Asia-Pacific. It calls for urgent action to improve care, diagnosis, and transition across the lifespan for those living with these diseases. PURPOSE: Rare bone disorders (RBDs) are often misdiagnosed or diagnosed late, causing irreversible complications that could have been prevented by early identification and intervention. This survey assessed awareness among healthcare providers across various specialties with the goals of identifying knowledge gaps as well as barriers in education, clinical practice, and health policy regarding RBDs.
methodsThe ASPIRE survey was designed by a steering committee of international experts and administered to attendees of an Asia-Pacific musculoskeletal congress held in Singapore. It included multiple-choice questions, short answers, and situational case studies.
resultsOf 106 clinician attendees, 96 completed the survey. While 71.9% of respondents had some knowledge of RBDs, only 36.5% had ever managed a patient with a RBD. Overall, 76.0% of respondents indicated not feeling qualified to diagnose or treat RBDs; 74.0% were unaware of any RBD national or international guidelines, and 66.7% were unaware of any new specific medications available in the last 5‒10 years to treat any RBD. Among those who attempted diagnosis of two clinical vignettes, only 46.3% correctly identified X-linked hypophosphatemia, and only 32.4% correctly identified hypophosphatasia. The survey also highlighted substantial barriers to effective RBD care, including gaps in medical education and training, and limited access to diagnostic tools and RBD specialists.
conclusionThis first of a kind survey provides evidence of the stark lack of awareness of RBDs in the Asia-Pacific region. Urgent attention is needed from educators, clinicians, and policymakers to address the educational, structural, and policy gaps identified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.